Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news headlines: Scancell, Immupharma, Touchstone, Wrestle, and more

Diversified Energy Company PLC (LSE:DEC, OTCQX:DECPF), responding to share price volatility, noted in a stock market statement that it has received inquiries from members of the United States House of Representatives Committee on Energy and Commerce, relating to the company’s well retirement processes and emissions.

In London, DEC shares were down 254p or 19.38% changing hands at £1,056.50 per share.

Read more

Pantheon Resources PLC (AIM:PANR, OTCQX:PTHRF) said it remains “laser-focused” on reaching final investment decisions (FID) for its oil fields under development in Alaska within five years.

Jay Cheatham, chief executive, said the aim was for the FID on Ahpun by the end of 2025 and FID on Kodiak by the end of 2028 and “to achieve sustainable market recognition of $5-$10 per barrel of 1P/1C recoverable resources".

Read more

Bitcoin (BTC) has snapped into action after a dour weekend, posting a 3% gain on Monday before continuing an upward trend throughout Tuesday morning.

At the time of writing, the benchmark cryptocurrency was trading above $43,000 on the BTC/USDT pair.

Read more

Empire Metal Ltd has identified more shallow-level titanium from the first five assays received from a four-hole reverse circulation (RC) drill programme at Pitfield in Western Australia.

A new shallow zone of bedded higher-grade TiO2 mineralisation was identified from the assays, in addition to extending the overall broad footprint of significant TiO2 mineralisation already discovered.

Read more

ImmuPharma PLC (AIM:IMM) said Simbec-Orion has been appointed as the contract research organisation (CRO) to carry out a phase III study of P140 (Lupuzor), a putative treatment for systemic lupus erythematosus (SLE).

The decision comes after a six-month evaluation process involving three different CROs. The appointment marks a pivotal step in advancing the drug towards regulatory approval.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK